Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Zoloft “Authorized” Generic Will Be Available From Ivax By Mid-2006

Executive Summary

Ivax will begin distributing an authorized generic version of Pfizer's Zoloft by mid-2006 under an agreement between the two companies

You may also be interested in...



Declaratory Judgment Ruling Will Add Uncertainty To Generic Launches

Generic companies are likely to face an increased threat of patent infringement lawsuits on the eve of launch following an appeals court ruling on the standards for seeking a declaratory judgment of noninfringement

Declaratory Judgment Ruling Will Add Uncertainty To Generic Launches

Generic companies are likely to face an increased threat of patent infringement lawsuits on the eve of launch following an appeals court ruling on the standards for seeking a declaratory judgment of noninfringement

Zocor, Zoloft And Pravachol Will Be Key Generic Switches For Medco In ’06

Medco sees a significant opportunity for growth in 2006 generic switches, Group President-National Accounts Timothy Wentworth says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel